Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) — Capital Reinvestment Ratio

Latest as of September 2025: 0.12x

Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) has a Capital Reinvestment Ratio of 0.12x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥37.78 Million) in capital expenditures (CN¥4.36 Million). See free cash flow generation of Zhuhai Rundu Pharmaceutical Co Ltd Class to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.12x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥37.78 Million
CNY

Capital Expenditures

CN¥4.36 Million
CNY

Data as of

Sep 2025
Most recent filing

Zhuhai Rundu Pharmaceutical Co Ltd Class A Capital Reinvestment Ratio (2011–2024)

This chart tracks Zhuhai Rundu Pharmaceutical Co Ltd Class A's Capital Reinvestment Ratio across 14 annual periods.

Annual Capital Reinvestment Ratio for Zhuhai Rundu Pharmaceutical Co Ltd Class A (2011–2024)

Year-by-year Capital Reinvestment Ratio for Zhuhai Rundu Pharmaceutical Co Ltd Class A from 2011 to 2024. For live market cap and broader valuation context, see 002923 market cap.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 0.38x CN¥211.19 Million CN¥81.25 Million ▼ -61.9%
2023 1.01x CN¥172.68 Million CN¥174.53 Million ▼ -45.8%
2022 1.86x CN¥135.01 Million CN¥251.75 Million ▲ +2.0%
2021 1.83x CN¥205.91 Million CN¥376.48 Million ▲ +78.3%
2020 1.03x CN¥250.35 Million CN¥256.74 Million ▼ -35.4%
2019 1.59x CN¥151.30 Million CN¥240.01 Million ▲ +118.8%
2018 0.73x CN¥159.04 Million CN¥115.31 Million ▲ +15.4%
2017 0.63x CN¥57.95 Million CN¥36.40 Million ▼ -7.5%
2016 0.68x CN¥94.07 Million CN¥63.87 Million ▼ -48.5%
2015 1.32x CN¥50.14 Million CN¥66.05 Million ▲ +298.7%
2014 0.33x CN¥58.01 Million CN¥19.17 Million ▼ -57.3%
2013 0.77x CN¥31.67 Million CN¥24.51 Million ▲ +161.1%
2012 0.30x CN¥70.01 Million CN¥20.75 Million ▼ -83.6%
2011 1.81x CN¥33.71 Million CN¥60.89 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow